Evidence map›Paper›PMID 42264600›Full record

ArticleMutation research. Genetic toxicology and environmental mutagenesis

Human aldo-keto reductases (AKR1C1-AKR1C3) increase the mutagenicity of environmental nitroarenes in the mammalian HPRT forward gene mutagenicity assay.

Anthony L Su, Cátia F Marques, Karam El-Bayoumy, Trevor M Penning

Abstract read
In one paragraph

Article in Mutation research. Genetic toxicology and environmental mutagenesis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anthony L SuDepartment of Systems Pharmacology & Translational Therapeutics and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.
Cátia F MarquesDepartment of Systems Pharmacology & Translational Therapeutics and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.
Karam El-BayoumyDepartment of Molecular and Precision Medicine, Penn State College of Medicine, Pennsylvania State University, Hershey, PA 17033-2360, United States.
Trevor M PenningDepartment of Systems Pharmacology & Translational Therapeutics and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States; Center of Excellence in Environmental Toxicology, Perelman School of Medicine, University of Pennsylvania, United States. Electronic address: penning@upenn.edu.

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Trevor M Penning · 2006 to 2026
$35.3M
Translational Research Training Program in Environmental Health SciencesT32ES019851 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Kara A Bernstein, Trevor M Penning · 2012 to 2026
$6.0M
Metabolic activation of nitroarenes and Nrf2-Keap1R01ES029294 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Trevor M Penning · 2019 to 2026
$3.6M
Thermo IQ-X high-resolution mass spectrometerS10OD034344 · OD · UNIVERSITY OF PENNSYLVANIA · PI MESAROS, A. CLEMENTINA · 2024 to 2024
$737k
NIEHS NIH HHS P30 ES013508NIEHS NIH HHS R01 ES029294NIEHS NIH HHS T32 ES019851NIH HHS S10 OD034344
6 · The paper itself

Abstract

The diesel exhaust constituent 1-nitropyrene (1-NP) is classified as a probable human carcinogen and other constituents 1,8-dinitropyrene (1,8-DNP) and 3-nitrobenzanthrone (3-NBA) are classified as possible human carcinogens by the International Agency for Research on Cancer. These nitroarenes are activated by nitroreduction via nitroso- and hydroxylamino- intermediates on route to the corresponding amine product(s). Two types of DNA adduct can occur in this sequence. First, the hydroxylamino- intermediate can undergo sulphonation or acetylation giving rise to a strong leaving group so that stable covalent adducts can form. Second, back oxidation of these air sensitive intermediates can give rise to reactive oxygen species and nitrogen species (ROS, RNS) so that oxidatively damaged bases can form. Human aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 play prominent roles in the nitroreduction of these nitroarenes in human lung cell lines. We now report that when AKR1C1-AKR1C3 are transfected into V79-4 cells we observe a significant increase in HPRT gene mutation. The mutation is dependent on AKR1C enzyme activity since isoform specific inhibitors reduced the number of mutant colonies formed. ROS scavengers reduced the number of mutant colonies formed with 1-NP, 1-8-DNP and 3-NBA in the presence of transfected AKR1C1. Ethyl gallate and the superoxide dismutase mimetic (MnTBAP) reduced the number of mutant colonies formed. Nitric oxide scavengers, 2-(4-carboxyphenyl)-4,5-dihydro-4,4,5,5-tetramethyl-1H-imidazoyl-1-oxy-3-oxide and uric acid, also reduced the number of mutant colonies formed. Our results suggest that both 8-oxo-dG and 8-nitro-dG lesions may contribute to the mutation observed. Since AKR1C1-AKR1C3 are potently induced by NRF2, its activation might increase the mutagenicity of nitroarenes in the context of diesel exhaust exposure.

Indexed as

MutagensPyrenesAldo-Keto Reductase Family 1 Member C3AnimalsBenz(a)AnthracenesCell LineDNA AdductsHumansMutagenicity Tests1-nitropyrene3-nitrobenzanthroneAKR1C3 protein, humanAldo-Keto Reductase Family 1 Member C3Benz(a)AnthracenesDNA AdductsMutagensPyrenes1,8-dinitropyrene1-nitropyrene3-nitrobenzanthroneCHO cellsMutationNitroreduction

Identifiers

PMID42264600
PMCPMC13256256

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.